Teva Pharmaceutical Industries Ltd. said it reached a national settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.
Under the terms, the Israeli generic drugmaker said Tuesday it would pay more than $3 billion over the next 13 years to states and local governments, plus another $100 million to Native American tribes over the period.